19
Views
23
CrossRef citations to date
0
Altmetric
Review

Chemokine receptor antagonists: novel therapeutics for inflammation and AIDS

Pages 1-18 | Published online: 23 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Trevor R. Norman. (2006) Prospects for the treatment of depression. Australian and New Zealand Journal of Psychiatry 40:5, pages 394-401.
Read now
Richard M Ransohoff & Kevin B Bacon. (2000) Chemokine receptor antagonism as a new therapy for multiple sclerosis. Expert Opinion on Investigational Drugs 9:5, pages 1079-1097.
Read now
. (1998) Interleukin-8 receptor antagonists. Expert Opinion on Therapeutic Patents 8:4, pages 471-473.
Read now

Articles from other publishers (19)

Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery 284 320 .
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery 237 283 .
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery 481 535 .
Waseem Ostwani & Thomas P. Shanley. 2014. Pediatric Critical Care Medicine. Pediatric Critical Care Medicine 101 126 .
Ronald E. Dechert, Carl F. Haas & Waseem Ostwani. (2012) Current Knowledge of Acute Lung Injury and Acute Respiratory Distress Syndrome. Critical Care Nursing Clinics of North America 24:3, pages 377-401.
Crossref
Michael Vish & Thomas P. Shanley. 2009. The Respiratory Tract in Pediatric Critical Illness and Injury. The Respiratory Tract in Pediatric Critical Illness and Injury 1 17 .
Trevor R. Norman. (2006) Prospects for the treatment of depression. Australian and New Zealand Journal of Psychiatry 40:5, pages 394-401.
Crossref
R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan & M. P. Knadler. (2003) METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS. Drug Metabolism and Disposition 31:9, pages 1142-1150.
Crossref
T. L. Sørensen, R. M. Ransohoff, J. Jensen & F. Sellebjerg. (2003) Evidence favoring the involvement of CC chemokine receptor (CCR) 5 in T-lymphocyte accumulation in optic neuritis. Acta Neurologica Scandinavica 107:3, pages 221-227.
Crossref
Amanda E.I. Proudfoot, Jeffrey P. Shaw, Christine A. Power & Timothy N.C. Wells. 2002. Universes in Delicate Balance. Universes in Delicate Balance 65 85 .
Amanda E.I. Proudfoot, Christine A. Power, Dennis J. Church, Dulce Soler & Matthias Mack. (2001) Cellular Assays of Chemokine Receptor Activation. Current Protocols in Pharmacology 14:1.
Crossref
Alexander Scheer & Amanda E.I. Proudfoot. (2001) Characterization of Chemokine Receptors. Current Protocols in Pharmacology 14:1.
Crossref
Alexandra Trkola, Timothy Wells & Amanda Proudfoot-Fichard. 2000. Cytokine Inhibitors. Cytokine Inhibitors.
A. N. Nicolaides. (2000) Investigation of Chronic Venous Insufficiency. Circulation 102:20.
Crossref
Craig W. Hendrix, Charles Flexner, Ronald T. MacFarland, Christen Giandomenico, Edward J. Fuchs, Ella Redpath, Gary Bridger & Geoffrey W. Henson. (2000) Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers. Antimicrobial Agents and Chemotherapy 44:6, pages 1667-1673.
Crossref
AE Frankel, JA McCubrey, MS Miller, S Delatte, J Ramage, M Kiser, GL Kucera, RL Alexander, M Beran, EP Tagge, RJ Kreitman & DE Hogge. (2000) Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias. Leukemia 14:4, pages 576-585.
Crossref
Françoise Tiberghien, Agnès Didier, Alain Bohbot & Francis Loor. (1999) The MultiScreen® filtration system to measure chemoattractant-induced release of leukocyte granule enzymes by differentiated HL-60 cells or normal human monocytes. Journal of Immunological Methods 223:1, pages 63-75.
Crossref
Amanda E. I. Proudfoot & Timothy N. C. Wells. 1999. Chemokines in Disease. Chemokines in Disease 313 322 .
Timothy N.C Wells, Christine A Power & Amanda E.I Proudfoot. (1998) Definition, function and pathophysiological significance of chemokine receptors. Trends in Pharmacological Sciences 19:9, pages 376-380.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.